Medicine and Health Sciences Commons^™

A Randomized,Double-Blind,Placebo-Controlled, Phaseiistudy Of Regorafenib Versus Placebo In Advanced/Metastatic,Treatment-Refractoryliposarcoma: Results From Thesarc024study, R. F. Riedel, K. Ballman, Y. Lu, S. Attia, E. T. Loggers, K. N. Ganjoo, M. B. Livingston, W. Chow, J. Wright, R. G. Maki, +10 Additional Authors Jan 2020

Management Of Pediatric Systemic Lupus Erythematosus: Focus On Belimumab, M. Guzman, J. S. Hui-Yuen Jan 2020

Social And Functional Outcomes With Two Doses Of Aripiprazole Lauroxil Vs Placebo In Patients With Schizophrenia: A Post-Hoc Analysis Of A 12-Week Phase 3 Efficacy Study, C. U. Correll, A. D. Stanford, A. Claxton, Y. Du, P. J. Weiden Jan 2019

Relationship Between The Timing Of Relapse And Plasma Drug Levels Following Discontinuation Of Cariprazine Treatment In Patients With Schizophrenia: Indirect Comparison With Other Second-Generation Antipsychotics After Treatment Discontinuation, C. U. Correll, R. Jain, J. M. Meyer, A. Periclou, T. Carrothers, A. Barabassy, M. Patel, W. Earley Jan 2019

Clinical Relevance Of Paliperidone Palmitate 3-Monthly In Treating Schizophrenia, M. Mathews, S. Gopal, I. Nuamah, L. Hargarter, A. J. Savitz, E. Kim, W. Tan, B. Soares, C. U. Correll Jan 2019

Long-Term Effectiveness Of Oral Second-Generation Antipsychotics In Patients With Schizophrenia And Related Disorders: A Systematic Review And Meta-Analysis Of Direct Head-To-Head Comparisons, T. Kishimoto, K. Hagi, M. Nitta, J. M. Kane, C. U. Correll Jan 2019

Abnormal Involuntary Movement Scale In Tardive Dyskinesia: Minimal Clinically Important Difference, M. Stacy, M. Sajatovic, J. M. Kane, A. J. Cutler, G. S. Liang, C. F. O'Brien, C. U. Correll Jan 2019

Oral Curcumin For Radiation Dermatitis: A Urcc Ncorp Study Of 686 Breast Cancer Patients, J. R. Wolf, C. E. Heckler, J. J. Guido, A. R. Peoples, J. S. Gewandter, M. Ling, V. P. Vinciguerra, T. Anderson, L. Evans, G. R. Morrow, +2 Additional Authors Jan 2018

Effects Of Vedolizumab Therapy On Extraintestinal Manifestations In Inflammatory Bowel Disease, M. Fleisher, J. Marsal, S. D. Lee, L. E. Frado, A. Parian, B. I. Korelitz, B. G. Feagan Jan 2018

Treatment Of Tardive Dyskinesia With Vmat-2 Inhibitors: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials, M. Solmi, G. Pigato, J. M. Kane, C. U. Correll Jan 2018

Initiating/Maintaining Long-Acting Injectable Antipsychotics In Schizophrenia/Schizoaffective Or Bipolar Disorder - Expert Consensus Survey Part 2, M. Sajatovic, R. Ross, S. N. Legacy, M. Byerly, J. M. Kane, F. Dibiasi, H. Fitzgerald, C. U. Correll Jan 2018

Tardive Dyskinesia Risk With First- And Second-Generation Antipsychotics In Comparative Randomized Controlled Trials: A Meta-Analysis, M. Carbon, J. M. Kane, S. Leucht, C. U. Correll Jan 2018